Get Started

RNXT

NASD RenovoRx, Inc.
Oct 29, 2026 · 5:31 AM ET LAST TRADE Market Closed

$1.42 ↓ -0.01 (-0.35%) Trading Down from the previous close of $1.43

YTD change
+69.03%
vs 20-day SMA
+8.83%
vs 200-day SMA
+29.19%

Price ranges

Previous day
$1.35 $1.46
open $1.42 close $1.43
+$0.01 (+0.35%)
Today
$0.00 $0.00
$1.42
Past week
$1.22 $1.46
from $1.23 now $1.42
+$0.19 (+15.45%)
Past month
$1.09 $1.61
from $1.56 now $1.42
-$0.14 (-8.97%)
This year
$0.77 $2.59
from $0.84 now $1.42
+$0.58 (+69.03%)

Price & Performance

+0.59 (+71.46%) / 6M

$0.6443$1.32$1.99$2.66Apr 29Jul 30Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 91.5% away from all-time highs of $16.74
  • RNXT is up 69% since the beginning of the year
  • RNXT is up 35% over the past 12 months
  • RNXT is down 9% over the past 1 month
  • 2% of all RNXT investors are betting against RNXT

RNXT reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +35.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.06
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $56.7M
Beta 2.07

Balance sheet & scale

IncomeN/A
Revenue$2.0M
Cash$9.5M
Debt$390.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $67.2M

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in 2009 and is headquartered in Mountain View, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $451.83 +0.87%
MRNA Moderna, Inc. $214.17 +2.98%
RVMD Revolution Medicines, Inc. $188.72 +1.34%
ROIV Roivant Sciences Ltd. $37.11 +1.56%
BNTX BioNTech SE Sponsored ADR $87.99 +1.07%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.